MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

MEDX 31.14

-0.1%

Oct 30 10:04 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (2178)	6/24/2009 3:53:03 AM
From: scaram(o)uche	2 Recommendations of 2240

>> The PR is hype -- possibly justified, but too soon to say -- without the numbers to back it up. << The two patients were taken OFF PROTOCOL. The Mayo physicians are not describing results of a Medarex clinical trial, they are talking about two patients who elected to have surgery and thus to leave a physician-sponsored trial. The Mayo physicians are therefore talking about two of two, they have every right to do so, and there is absolutely NO reason that they shouldn't. It is difficult as heck to recruit naive prostate patients.... competition among sites is horrific. This research was supported by the Department of Defense, The Richard M. Schulze Family Foundation, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic Center for Translational Science Activities. Medarex Inc. provided the free study drug.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next